期刊文献+

慢性肾炎患者发生骨质疏松的危险因素及诊断模型的构建

Risk factors and diagnostic model establishment of suffering from osteoporosis in patients with chronic nephritis
下载PDF
导出
摘要 目的分析慢性肾炎患者发生骨质疏松的危险因素,并构建诊断模型。方法回顾性分析138例慢性肾炎患者的临床资料,根据骨密度值将患者分为骨质疏松组(n=50)与非骨质疏松组(n=88)。记录两组患者的性别、年龄、体质指数、慢性肾炎病程、糖尿病史、吸烟史、激素服用时间,并检测两组患者的骨代谢和生化指标,即血磷、血钙、血清尿酸、血肌酐、骨碱性磷酸酶(BALP)、碱性磷酸酶(ALP)、全段甲状旁腺激素(iPTH)、25-羟基维生素D_(3)[25(OH)D_(3)]、估算肾小球滤过率(eGFR)。采用Logistic回归分析慢性肾炎患者发生骨质疏松的危险因素并构建诊断模型;采用受试者工作特征(ROC)曲线评价模型的诊断效能并确定诊断阈值。结果单因素分析结果显示,相比于非骨质疏松组,骨质疏松组激素服用时间≥3年的患者比例更高,BALP、iPTH水平更高,25(OH)D_(3)水平、eGFR更低(均P<0.05)。多因素Logistic回归分析结果显示,激素服用时间≥3年、BALP和iPTH水平升高是慢性肾炎患者发生骨质疏松的危险因素,25(OH)D_(3)水平、eGFR升高是慢性肾炎患者发生骨质疏松的保护因素(均P<0.05)。Logistic回归诊断模型为Logit P=-7.955+1.583×激素服用时间+0.850×BALP+0.240×iPTH-0.384×25(OH)D_(3)-0.071×eGFR,该模型的ROC曲线下面积为0.935,灵敏度为94.00%,特异度为92.05%,正确诊断率为92.75%。结论激素服用时间≥3年、BALP和iPTH水平升高的慢性肾炎患者发生骨质疏松的风险增加,25(OH)D_(3)水平、eGFR升高者发生骨质疏松的风险降低;根据上述影响因素构建的Logistic诊断模型能有效评估慢性肾炎患者发生骨质疏松的风险。 Objective To analyze the risk factors for suffering from osteoporosis in patients with chronic nephritis,and to establish a diagnostic model.Methods The clinical data of 138 patients with chronic nephritis were retrospectively analyzed,and the patients were assigned to osteoporosis group(n=50)or non-osteoporosis group(n=88)according to bone mineral density.The gender,age,body mass index,disease course of chronic nephritis,history of diabetes mellitus,smoking history,hormone administration duration were recorded in both groups;in addition,bone metabolism and biochemical indexes,namely,serum phosphorus,serum calcium,serum uric acid,serum creatinine,bone alkaline phosphatase(BALP),alkaline phosphatase(ALP),intact parathyroid hormone(iPTH),25-hydroxyvitamin D_(3)(25(OH)D_(3)),and estimated glomerular filtration rate(eGFR)were measured in the two groups.The Logistic regression was performed to analyze the risk factors for suffering from osteoporosis in patients with chronic nephritis,and to establish a diagnostic model.The receiver operating characteristic(ROC)curve was employed to evaluated the diagnostic efficiency of the model,and determine the diagnostic threshold.Results The results of univariate analysis revealed that the osteoporosis group exhibited a higher proportion of patients with hormone administration duration≥3 years,higher levels of BALP and iPTH,and lower 25(OH)D_(3) level and eGFR as compared with the non-osteoporosis group(all P<0.05).The results of multivariate Logistic regression analysis revealed that hormone administration duration≥3 years,the elevations of BALP and iPTH levels were the risk factors for suffering from osteoporosis in patients with chronic nephritis,and the elevations of 25(OH)D_(3) level and eGFR were the protective factors for suffering from osteoporosis in patients with chronic nephritis(all P<0.05).The Logistic regression diagnostic model was Logit P=-7.955+1.583×hormone administration duration+0.850×BALP+0.240×iPTH-0.384×25(OH)D_(3)-0.071×eGFR,and the area under the curve of this model was 0.935,the sensitivity was 94.00%,the specificity was 92.05%,and the diagnostic accuracy was 92.75%.Conclusion The chronic nephritis patients with hormone administration duration≥3 years,and with the elevations of BALP and iPTH levels are at a increased risk of suffering from osteoporosis,and the patients with the elevations of 25(OH)D_(3) level and eGFR are at a decreased risk of suffering from osteoporosis.The established Logistic diagnostic model based on aforesaid influencing factors can effectively evaluate the risk of suffering from osteoporosis in patients with chronic nephritis.
作者 潘习彰 叶娟 刘园园 张东霞 PAN Xi-zhang;YE Juan;LIU Yuan-yuan;ZHANG Dong-xia(Department of Nephrology,Guidong people′s Hospital of Guangxi Zhuang Autonomous Region,Wuzhou 543001,Guangxi,China;Department of Nephrology,the People′s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,Guangxi,China)
出处 《广西医学》 CAS 2022年第16期1874-1878,共5页 Guangxi Medical Journal
基金 广西科技计划项目(桂科AB16380229)。
关键词 慢性肾炎 骨质疏松 危险因素 诊断模型 Chronic nephritis Osteoporosis Risk factors Diagnostic model
  • 相关文献

参考文献17

二级参考文献138

  • 1Nils Ewald,Philip D Hardt.Diagnosis and treatment of diabetes mellitus in chronic pancreatitis[J].World Journal of Gastroenterology,2013,19(42):7276-7281. 被引量:25
  • 2王景,蒋欣峰,李小梅,洪苑.绝经后老年骨质疏松患者血清脂联素与骨代谢生化指标的相关性[J].中国老年学杂志,2015,35(2):360-361. 被引量:20
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:710
  • 4王红.浅析糖皮质激素性骨质疏松症[J].医学信息,2012,11(25):383.
  • 5Ravani P, Malberti F, Tripepi G, eta]. Vitamin D levels and patient outcome in chronic kidney disease [ J ]. Kidney Int,2009,75 (l) : 88 - 95.
  • 6Hussain A N, Alkhenizan A H, EI Shaker M, et al. Increasing trends and significance of hypovitaminosis D:a population-based study in the Kingdom of Saudi Arabia[ J ]. Arch Osteoporos ,2014, 9 : 190 -4.
  • 7Satirapoj B,Limwannata P,Chaiprasert A,et al. Vitamin D insutt]- ciency and deficiency with stages of chronic kidney disease in an Asian population [ J ]. BMC Nephro1,2013,14 : 206 - 10.
  • 8Kendrick J, Targher G, Smits G, et al. 25-Hy&)xyvitamin D defi- cieney and inflammation and their association with hemoglobin lev- els in chronic kidney disease [ J ]. Am J Nephrol,2009,30 ( 1 ) :64 -72.
  • 9Pekkanen M P, Ukkola O, Hedberg P, et a|. Serum 25- hydroxyvitamin D is associated with major cardiovascular risk fac- tors and cardiac structure and function in patients with coronary ar- tery disease [J]. Nutr Metab Cardiovasc Dis,2015,25(5 ) :471 - 8.
  • 10Metzger M, Houillier P, Gauci C, et al. Relation between circulating levels of 25 ( OH ) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold [ J ]. J Clin Endocrinol Metab,2013,98 (7) :2922 - 8.

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部